| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/18/2013 | US20130096130 CGRP Receptor Antagonists |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096122 Fused heterocyclic compounds as ion channel modulators |
| 04/18/2013 | US20130096120 Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | US20130096119 Isoquinolin-3-Ylurea Derivatives |
| 04/18/2013 | US20130096118 Carboline carboxamide compounds useful as kinase inhibitors |
| 04/18/2013 | US20130096115 Methods for treating autism |
| 04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | US20130096110 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/18/2013 | US20130096104 Imidazopyridine compounds, compositions and methods of use |
| 04/18/2013 | US20130096103 Imidazoquinoline compounds |
| 04/18/2013 | US20130096101 Inhibitors of hcv ns5a |
| 04/18/2013 | US20130096089 Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders |
| 04/18/2013 | US20130096084 Novel heterocyclic compounds as erk inhbitors |
| 04/18/2013 | US20130095057 Compounds for the treatment of clostridium difficile-associated disease |
| 04/18/2013 | US20130092879 Compounds for electronic devices |
| 04/18/2013 | CA2852060A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them |
| 04/18/2013 | CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | CA2851364A1 8-carbamoyl-2-(2,3-di substituted pyrid-6-yl)-1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | CA2851155A1 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | CA2848197A1 Protein kinase inhibitors |
| 04/18/2013 | CA2848131A1 Solid forms of nematocidal sulfonamides |
| 04/17/2013 | EP2581376A1 Matrinic acid/ matrine derivatives and preparation methods and uses thereof |
| 04/17/2013 | EP2581375A2 Improved methods for the preparation of quinoxaline derivatives |
| 04/17/2013 | EP2581374A1 Preparation of tetrahydropyrido[4,3-b]indole derivatives |
| 04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
| 04/17/2013 | EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/17/2013 | EP2580217A2 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580216A2 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580215A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580214A2 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580213A2 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS |
| 04/17/2013 | EP2580212A1 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract |
| 04/17/2013 | EP2580208A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 04/17/2013 | EP2579877A1 Morpholino pyrimidines and their use in therapy |
| 04/17/2013 | CN103052636A D2 antagonists, methods of synthesis and methods of use |
| 04/17/2013 | CN103045232A Dihydro-pentacene-olefin organic light-emitting material, preparation method and application of dihydro-pentacene-olefin organic light-emitting material |
| 04/17/2013 | CN103045230A Polyethylene terephthalate (PET) type Fe<3+> fluorescent probe and preparation method and application thereof |
| 04/17/2013 | CN103044446A Heterocycle quinoline derivatives as well as medicinal salts, preparation method and medicinal application thereof |
| 04/17/2013 | CN103044432A 双环杂芳基化合物 Bicyclic heteroaryl compounds |
| 04/17/2013 | CN103044424A Method for enriching and purifying matrine in kuh-seng |
| 04/17/2013 | CN103044423A Substituted pyridine-2-ketone compounds and preparation method thereof |
| 04/17/2013 | CN103044422A Preparation method of praziquantel |
| 04/17/2013 | CN103044421A Palladium-catalyzed preparation method of benzimidazo-isoquinolin |
| 04/17/2013 | CN103044420A Phenanthroline derivative, as well as preparation method and application thereof |
| 04/17/2013 | CN103044419A Method for synthesizing pirenzepine hydrochloride |
| 04/17/2013 | CN103044418A Asymmetric synthesis method, relevant raw materials and preparation method of (S,S)-2,8-diazabicyclo[4,3,0] nonane |
| 04/17/2013 | CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof |
| 04/17/2013 | CN102432608B Method for synthesizing optically active tetrahydro-beta-carboline derivative through catalysis of chiral spirocyclic phosphoric acid |
| 04/17/2013 | CN102336753B Method for synthesizing 4-(dicyanomethylene)-2-tert-butyl-6-(1,1,7,7-tetramethyljulolidin-4-yl-vinyl)-4H-pyran |
| 04/17/2013 | CN102329735B Method for preparing curvularin and indolizidine alkaloid and application |
| 04/17/2013 | CN102285986B Industrialized purification method of moxifloxacin |
| 04/17/2013 | CN102234276B Preparation method of optical isomer of stepholidine or its derivative and intermediate used in the method |
| 04/17/2013 | CN102153585B Synthesis method of minodronate midbody and synthesis of minodronate |
| 04/17/2013 | CN102105472B Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 04/17/2013 | CN101952283B Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 04/17/2013 | CN101918406B Compounds for the treatment of hepatitis c |
| 04/17/2013 | CN101903380B 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 04/17/2013 | CN101679411B MAPK/ERK kinase inhibitors |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101553483B 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/16/2013 | US8420820 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 04/16/2013 | US8420819 Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization |
| 04/16/2013 | US8420817 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/16/2013 | US8420816 Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK |
| 04/16/2013 | US8420815 Anti-cancer agents based on N-acyl-2, 3-dihydro-1H-pyrrolo[2,3-b] quinoline derivatives and a method of making |
| 04/16/2013 | US8420664 A3 adenosine receptor allosteric modulators |
| 04/16/2013 | US8420646 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/16/2013 | US8420632 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | CA2637204C Substituted quinolones iii |
| 04/16/2013 | CA2559128C Kinase inhibitors |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/11/2013 | WO2013052417A1 Pyrrolopyrimidine compounds for the treatment of cancer |
| 04/11/2013 | WO2013052153A1 Blends of organic semiconductor compounds and electrically insulating amorphous polymers, methods and devices |
| 04/11/2013 | WO2013051672A1 Medicinal agent comprising thiazolidine derivative or salt thereof as active ingredient |
| 04/11/2013 | WO2013051639A1 Pyrazoloquinoline derivative |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013051414A1 Pyrroloquinoline quinone alcohol adduct |
| 04/11/2013 | WO2013050938A1 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives |
| 04/11/2013 | WO2013050437A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | WO2013050421A1 Herbicidal pyridazinone derivatives |
| 04/11/2013 | WO2013009013A3 Novel compound and organic electronic device using same |
| 04/11/2013 | US20130090352 Tetrahydroquinoline amide m1 receptor positive allosteric modulators |
| 04/11/2013 | US20130090351 Analogues for the treatment or prevention of flavivirus infections |
| 04/11/2013 | US20130090331 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 04/11/2013 | US20130090326 Antimicrobial Compounds and Methods of Making and Using the Same |
| 04/11/2013 | US20130090323 Heterocyclic compounds and their uses |
| 04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/11/2013 | CA2851142A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | CA2850617A1 Pyrrolopyrimidine compounds for the treatment of cancer |
| 04/11/2013 | CA2850013A1 Herbicidal pyridazinone derivatives |
| 04/10/2013 | EP2578583A1 Fused heterocyclic derivatives and methods of use |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |
| 04/10/2013 | EP2576555A1 1, 8 -diazaspiro [4.5]decane- 2, 4 -dione derivatives useful as pesticides |
| 04/10/2013 | EP2576554A1 1, 8 -diazaspiro [4.5]decane- 2, 4 -dione derivatives useful as pesticides |
| 04/10/2013 | EP2576553A2 Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam |
| 04/10/2013 | EP2576552A2 Benzoquinolone inhibitors of vmat2 |